The company, which has a focus on next generation technologies in the diagnostics space after building an AI (artificial intelligence) platform, has already invested USD 6 million earlier into genetics and specialised testing coverage from prenatal to oncology, neurology and nephrology, among other segments.
हिन्दी 
English